“The dignity of the blood donor is eroded by poverty. The dignity of the patient is endangered by that poverty. And the law stands silent between them.”
She sold her blood to pay for school. He received her blood to survive surgery. Neither knew the other’s name. Neither knew that the system that connected them was built on poverty, desperation, and a regulatory vacuum that turns life-saving into life-threatening.
Consider “Josephine”—not her real name, but her real story. She represents thousands of young Nigerians who sell their blood to survive. A 20-year-old undergraduate in Lagos, she enters a private hospital every three months and sells a pint for ₦40,000 to ₦70,000. She uses the money for university fees, for food, for survival.
Josephine knows the medical advice: wait for four months between donations. She knows she is weakening herself. But as many young donors have told researchers, the danger seems less frightening than the hunger and poverty they confront daily.
Her blood is screened that day. A rapid test kit checks for HIV, hepatitis B, hepatitis C. It shows negative. The hospital transfers her blood—for a price. Three months later, Josephine tests positive for hepatitis B. The virus was in her blood that day, but the rapid test could not detect it—it was in the “window period,” that dangerous gap between infection and detectability.
The patient who received her blood? Untraceable. Unwarned. At risk.
This is not a medical error. This is the system.
Nigeria’s blood supply is not primarily a gift. It is a commodity. The majority of the nation’s blood comes from commercial donors—paid, professionalised, desperate—not from voluntary donors or family replacement. The poor sell to survive. The wealthy buy to survive. And the law that should protect both is largely absent.
Studies consistently show significantly higher rates of transfusion-transmissible infections among paid donors compared to voluntary donors. The patient on the operating table who receives blood from a commercial donor faces substantially higher risk of HIV, hepatitis B, and hepatitis C—several times higher than if the blood came from a volunteer.
Blood Screening Technology Compounds The Danger
Most Nigerian hospitals use rapid test kits—quick, cheap, but blind to the “window period,” those early weeks when infection is present but undetectable. Nucleic Acid Tests (NATs) can catch these window-period infections, but as health authorities admit, they are “not yet universally available” in Nigeria.
Even When Screening Works, The System Fails
There is no national donor registry. No database. No information management system that can trace a unit of blood from the donor’s vein to the patient’s vein. If Josephine’s contaminated blood is discovered weeks later, there is no mechanism to find the patient who received it. No recall. No warning. No accountability.
The National Blood Service Act 2021
It was a landmark—mandating a transition to voluntary donation and establishing a regulatory framework. But four years later, the Act’s provisions remain largely unimplemented. No national blood service infrastructure exists. No donor registry operates. No enforcement mechanism watches over the veins of the desperate.
What experts call “blood racketeering”—the illegal commercialisation of blood collection—flourishes where desperation meets weak regulation.
The Law Has Words. In Nigeria Today, It Has No Teeth
We must ask the dignity question directly…
Is it dignified to receive blood bought from hunger? To transfuse into a patient’s veins the desperation of a student who must choose between education and anemia? The wealthy receive life; the poor sell their bodies; and neither meets the other’s gaze.
Is it dignified to sell your blood to survive? The National Health Act speaks of the right to health. But for Josephine, health is a luxury she cannot afford. She must sell her blood to buy her future, risking her present, trusting a system that cannot protect her or those she sustains.
Who owns the blood? The donor who gives it, hungry and hopeful? The patient who receives it, fearful and grateful? The hospital that profits from both, screening inadequately, tracing nothing, accountable to no one?
The dignity of the blood donor is eroded by poverty. The dignity of the patient is endangered by that poverty. And the law stands silent between them.
Nigeria Does Not Need New Blood. We Need A New Law
First, a mandatory national donor registry—every unit of blood traceable from vein to vein, donor to recipient, with digital records that enable instant recall if contamination is discovered.
Second, universal NAT screening—eliminate the window period risk that rapid kits cannot catch. The cost of NAT is less than the cost of treating transfusion-transmitted HIV or hepatitis.
Third, criminalise commercial blood donation—transition to 100 per cent voluntary non-remunerated donation, with penalties for hospitals that buy blood from the desperate. The National Blood Service Act 2021 must be enforced, not ignored.
Fourth, the patient’s right to know—mandatory disclosure of whether blood is from voluntary or commercial sources, with informed consent that includes infection risk differentials. The patient must choose knowingly, not receive blindly.
Josephine had an identity. So does the patient who received her blood. But the system that connected them had no record, no accountability, no dignity. It was a marketplace, not a lifeline. A transaction, not a gift.
We passed laws that speak of safe blood. We maintain practices that sell unsafe blood. We promise patients protection. We deliver them poverty-stricken plasma, screened inadequately, and traced never.
It is time our law learned to trace—to protect the donor who gives, the patient who receives, and the trust that must flow between them. For the blood we share is not merely medical. It is human—and it must never become a marketplace of desperation.
